Market revenue in 2023 | USD 388.8 million |
Market revenue in 2030 | USD 558.2 million |
Growth rate | 5.3% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 51.29% in 2023. Horizon Databook has segmented the Latin America interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The interventional cardiology devices market in Latin America is experiencing growth through product expansion by market players. Companies are introducing innovative devices such as DESs, balloons, and imaging technologies, catering to the region's increasing demand for advanced cardiovascular treatments.
For instance, in March 2024, Boston Scientific Corporation secured approval from the U.S. FDA for its AGENT DCB designed to address coronary In-Stent Restenosis (ISR) in individuals with coronary artery disease. ISR entails the blockage or constriction of a stented vessel due to plaque or scar tissue.
Furthermore, the expansion of companies like Terumo Cardiovascular into Latin America contributes to growth of the interventional cardiology devices market, enhancing access to advanced cardiovascular technologies & improving patient outcomes.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America interventional cardiology devices market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account